Multicenter surveillance of < em > in vitro < /em > activities of cefepime-zidebactam, cefepime-enmetazobactam, omadacycline, eravacycline, and comparator antibiotics against < em > Enterobacterales, Pseudomonas aeruginosa < /em > , and < em > Acinetobacter baumannii < /em > complex causing bloodstream infection in Taiwan, 2020

CONCLUSIONS: : The efficacy of novel antibiotics against important drug-resistant GNB must be monitored and validated during the clinical treatment of patients.PMID:34933656 | DOI:10.1080/14787210.2022.2021876
Source: Expert Review of Anti-Infective Therapy - Category: Infectious Diseases Authors: Source Type: research